Home/Filings/4/0000899243-18-012150
4//SEC Filing

Stewart Robert A 4

Accession 0000899243-18-012150

CIK 0001723128other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:33 PM ET

Size

7.8 KB

Accession

0000899243-18-012150

Insider Transaction Report

Form 4
Period: 2018-05-07
Stewart Robert A
DirectorPresident & CEO
Transactions
  • Award

    Stock Option

    2018-05-07+681,199681,199 total
    Exercise: $15.01Exp: 2028-05-07Class A Common Stock (681,199 underlying)
  • Award

    Restricted Stock Units

    2018-05-07+333,111333,111 total
    Class A Common Stock (333,111 underlying)
Footnotes (3)
  • [F1]The option vests in four equal annual installments beginning on May 07, 2019.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001476493

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:33 PM ET
Size
7.8 KB